Guidance

NDTMS: recording data on blood-borne virus interventions

Guidance on recording data about blood-borne virus interventions on the national drug treatment monitoring system (NDTMS).

• From: Public Health England
• Published: 20 April 2017
• Last updated: 16 March 2020 — See all updates

This publication was withdrawn on 29 April 2024

This page has been withdrawn because it’s out of date. For up-to-date information about the National Drug Treatment Monitoring System (NDTMS), see core data set documentation on the NDTMS website.

Documents

[Withdrawn] Guidance for recording data about blood-borne virus interventions on the NDTMS

Ref: PHE publications gateway number: GW-1171

PDF, 436 KB, 16 pages

This file may not be suitable for users of assistive technology.

Request an accessible format.

If you use assistive technology (such as a screen reader) and need a version of this document in a more accessible format, please email publications@phe.gov.uk. Please tell us what format you need. It will help us if you say what assistive technology you use.

Details

Drug and alcohol treatment providers for adults, young people and secure settings can use this guidance to record blood borne virus (BBV) information in the NDTMS. This includes recording information on hepatitis B, hepatitis C and HIV.

This document describes what data about BBV interventions is required for the NDTMS dataset and how to respond to the questions. It answers some of the queries that may come up when recording BBV information.

Published 20 April 2017
Last updated 16 March 2020 + show all updates

1. 16 March 2020

   Added March 2020 blood borne virus (BBV) update.

2. 20 April 2017

   First published.